D-002 (beeswax alcohols): concurrent joint health benefits and gastroprotection

about

D-002 (beeswax alcohols): concurrent joint health benefits and gastroprotection

Item

http://www.wikidata.org/entity/Q26824177

description

2015 nî lūn-bûn

@nan

2015 թուականին հրատարակուած գիտական յօդուած

@hyw

2015 թվականին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

D-002 (beeswax alcohols): concurrent joint health benefits and gastroprotection

@ast

D-002 (beeswax alcohols): concurrent joint health benefits and gastroprotection

@en

D-002 (beeswax alcohols): concurrent joint health benefits and gastroprotection

@nl

type

Item

label

D-002 (beeswax alcohols): concurrent joint health benefits and gastroprotection

@ast

D-002 (beeswax alcohols): concurrent joint health benefits and gastroprotection

@en

D-002 (beeswax alcohols): concurrent joint health benefits and gastroprotection

@nl

prefLabel

D-002 (beeswax alcohols): concurrent joint health benefits and gastroprotection

@ast

D-002 (beeswax alcohols): concurrent joint health benefits and gastroprotection

@en

D-002 (beeswax alcohols): concurrent joint health benefits and gastroprotection

@nl

P1476

D-002 (beeswax alcohols): concurrent joint health benefits and gastroprotection

@en

P2093

Carbajal D

http://www.w3.org/2001/XMLSchema#string

Mas R

http://www.w3.org/2001/XMLSchema#string

Molina V

http://www.w3.org/2001/XMLSchema#string

P2860

Compartmental and temporal dynamics of chronic inflammation and airway remodelling in a chronic asthma mouse model

Pathogenesis of gastroduodenal lesions induced by non-steroidal anti-inflammatory drugs

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

Cyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular risk

Neutrophil recruitment and function in health and inflammation

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review.

OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence.

Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery.

Need to develop new nonsteroidal anti-inflammatory drug formulations.

P304

127-34

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/0250-474X.156542

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26009643

http://www.w3.org/2001/XMLSchema#string

P932

4442459

http://www.w3.org/2001/XMLSchema#string